Skip to main content
SpringerLink
Log in

ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer—The Randomized Multicenter Phase II NEPAFOX Trial

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Krankenhaus Nordwest, University Cancer Center (UCT) Frankfurt, Frankfurt, Germany

    Thorsten O. Goetze MD, PhD, Alexander Reichart MD, PhD, Ulli S. Bankstahl MSc, Wael Hozaeel MD, PhD & Salah-Eddin Al-Batran MD, PhD

  2. University Cancer Center (UCT) Frankfurt, Goethe Universität, Frankfurt, Germany

    Thorsten O. Goetze MD, PhD & Salah-Eddin Al-Batran MD, PhD

  3. Institut für Klinische Krebsforschung IKF am Krankenhaus Nordwest, Frankfurt, Germany

    Thorsten O. Goetze MD, PhD, Claudia Pauligk PhD, Maria Loose PhD & Salah-Eddin Al-Batran MD, PhD

  4. Krankenhaus Nordwest, Allgemein-, Viszeral- und Minimal Invasive Chirurgie, Frankfurt, Germany

    Thomas W. Kraus MD, PhD & Moustafa Elshafei MD, PhD

  5. Klinik für Allgemein-, Viszeral-, Transplantations- und Thoraxchirurgie, Universitätsklinikum Frankfurt, Frankfurt, Germany

    Wolf O. Bechstein MD, PhD

  6. Gastrointestinale Onkologie, Universitätsklinikum Frankfurt, Frankfurt, Germany

    Jörg Trojan MD, PhD

  7. DONAUISAR Klinikum Deggendorf, Viszeral-, Thorax- und Gefäßchirurgie, Deggendorf, Germany

    Matthias Behrend MD, PhD

  8. Klinikum Wolfsburg, MedizinischeKlinik II, Wolfsburg, Germany

    Nils Homann MD, PhD

  9. Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Magdeburg, Magdeburg, Germany

    Marino Venerito MD, PhD

  10. Klinik für Gastroenterologie, Gastroenterologische Onkologie, Hepatologie, Infektiologie und Pneumologie, Klinikum Stuttgart, Stuttgart, Germany

    Wolfram Bohle MD, PhD

  11. Onkologische Schwerpunktpraxis Celle, Celle, Germany

    Michael Varvenne MD, PhD

  12. Agaplesion Markus Krankenhaus, Hämatologie/Onkologie, Frankfurt, Germany

    Claus Bolling MD, PhD

  13. Klinik für Hämatologie, Onkologie und Palliativmedizin, Augusta-Kranken-Anstalt Bochum, Bochum, Germany

    Dirk M. Behringer MD, PhD

  14. Gemeinschaftspraxis für Hämatologie und Onkologie Münster, Münster, Germany

    Karsten Kratz-Albers MD, PhD

  15. 5. Medizinische Klinik, Hämatologie/ Onkologie, Klinikum Nürnberg Nord/Paracelsus Medizinische Privatuniversität, Nuremberg, Germany

    Gabriele M. Siegler MD, PhD

Authors
  1. Thorsten O. Goetze MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander Reichart MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulli S. Bankstahl MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudia Pauligk PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Loose PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thomas W. Kraus MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Moustafa Elshafei MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wolf O. Bechstein MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jörg Trojan MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Matthias Behrend MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nils Homann MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Marino Venerito MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Wolfram Bohle MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Michael Varvenne MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Claus Bolling MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Dirk M. Behringer MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Karsten Kratz-Albers MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Gabriele M. Siegler MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Wael Hozaeel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Salah-Eddin Al-Batran MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thorsten O. Goetze MD, PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goetze, T.O., Reichart, A., Bankstahl, U.S. et al. ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer—The Randomized Multicenter Phase II NEPAFOX Trial. Ann Surg Oncol 31, 4121–4122 (2024). https://doi.org/10.1245/s10434-024-15145-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-024-15145-8

Search

Navigation